BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.76B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$2.01B |
| 4 |
Tesla
TSLA
|
+$1.68B |
| 5 |
Snowflake
SNOW
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
Alibaba
BABA
|
+$1.25B |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.26% |
| 2 | Healthcare | 13.81% |
| 3 | Financials | 13.25% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RJET
3301
Republic Airways Holdings
RJET
$962M
| $18.8M | ﹤0.01% |
163,791
+4,582
| +3% | +$570K |
|
3302
Rafael Holdings
RFL
$103M
| $18.8M | ﹤0.01% |
620,561
-14,401
| -2% | -$661K |
|
3303
Harmony Gold Mining
HMY
$12B
| $18.8M | ﹤0.01% |
5,967,252
+269,320
| +5% | +$989K |
|
3304
TherapeuticsMD
TXMD
$24.1M
| $18.8M | ﹤0.01% |
506,131
+9,332
| +2% | +$414K |
|
|
EBTC
3305
DELISTED
Enterprise Bancorp
EBTC
| $18.8M | ﹤0.01% |
521,833
-35,896
| -6% | -$1.2M |
|
|
SOHU
3306
Sohu.com
SOHU
$369M
| $18.8M | ﹤0.01% |
899,729
-165,395
| -16% | -$3.53M |
|
|
YELL
3307
DELISTED
Yellow Corporation Common Stock
YELL
| $18.7M | ﹤0.01% |
3,316,689
+19,778
| +0.6% | +$115K |
|
3308
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.8B
| $18.7M | ﹤0.01% |
198,139
-11,814,138
| -98% | -$1.13B |
|
3309
South Plains Financial
SPFI
$858M
| $18.7M | ﹤0.01% |
766,943
-1,731
| -0.2% | -$40.2K |
|
3310
HBT Financial
HBT
$1.35B
| $18.7M | ﹤0.01% |
1,201,297
-110,718
| -8% | -$1.79M |
|
3311
Atlanticus Holdings
ATLC
$1.48B
| $18.6M | ﹤0.01% |
351,457
-70,224
| -17% | -$3.43M |
|
|
LOTZ
3312
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
| $18.6M | ﹤0.01% |
4,893,656
+1,342,527
| +38% | +$5.79M |
|
3313
Afya
AFYA
$1.26B
| $18.6M | ﹤0.01% |
944,348
-3,982
| -0.4% | -$90.3K |
|
3314
Banco Bilbao Vizcaya Argentaria
BBVA
$158B
| $18.6M | ﹤0.01% |
2,828,103
+140,799
| +5% | +$909K |
|
3315
Black Diamond Therapeutics
BDTX
$116M
| $18.5M | ﹤0.01% |
2,190,630
+36,418
| +2% | +$360K |
|
3316
Comscore
SCOR
$108M
| $18.5M | ﹤0.01% |
237,423
+886
| +0.4% | +$70.2K |
|
|
PSTX
3317
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $18.5M | ﹤0.01% |
2,533,139
-8,686
| -0.3% | -$74.5K |
|
3318
Treace Medical Concepts
TMCI
$293M
| $18.5M | ﹤0.01% |
686,235
+3,894
| +0.6% | +$107K |
|
|
UGIC
3319
DELISTED
UGI Corporation
UGIC
| $18.5M | ﹤0.01% |
+183,676
| New | +$19.3M |
|
|
BCEL
3320
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $18.4M | ﹤0.01% |
2,960,456
+84,906
| +3% | +$566K |
|
3321
Bolt Biotherapeutics
BOLT
$6.63M
| $18.4M | ﹤0.01% |
72,726
+25,633
| +54% | +$7.24M |
|
|
SURF
3322
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $18.4M | ﹤0.01% |
2,424,943
-119,990
| -5% | -$768K |
|
|
DRRX
3323
DELISTED
DURECT Corp
DRRX
| $18.4M | ﹤0.01% |
1,434,144
+3,923
| +0.3% | +$53.2K |
|
|
CCRD
3324
DELISTED
CoreCard
CCRD
| $18.4M | ﹤0.01% |
451,985
-2,896
| -0.6% | -$103K |
|
|
HGEN
3325
DELISTED
HUMANIGEN, INC.
HGEN
| $18.3M | ﹤0.01% |
3,094,486
+56,793
| +2% | +$798K |
|
Similar funds
BlackRock's Q3 2021 Portfolio in Review
As of Q3 2021, BlackRock held 5,803 positions worth $3.57T, down 0.58% from $3.59T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2021 filing shows 283 new, 2,199 increased, 2,669 reduced and 164 closed positions. Its largest new stake was GXO Logistics: 8,566,775 shares worth $672M. The largest sale was Alexion Pharmaceuticals, an estimated $3.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2021 buy was GXO Logistics: 8,566,775 shares worth $672M.
- BlackRock added most to Moderna in Q3 2021, an estimated $2.76B increase.
- BlackRock's biggest Q3 2021 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.28B.
- BlackRock fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.21B.
- BlackRock's ten largest holdings make up 19% of its $3.57T portfolio in Q3 2021.
- BlackRock opened 283 new positions and closed 164 in Q3 2021.
- BlackRock's portfolio value fell 0.58% quarter-over-quarter to $3.57T.
Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.